Stock Exchange Announcement
STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH)
Fisher & Paykel Healthcare provides Options & Performance Share Rights Update
Auckland, New Zealand, 5 September 2025 – Fisher & Paykel Healthcare Corporation Limited today announces that 412,417 Options and 130,857 Performance Share Rights to acquire ordinary shares in the Company issued on 4 September 2020 under the Company’s discretionary long term variable remuneration plans have lapsed due to the conditions for vesting having not been met.
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in over 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.
Contacts:
Media
Karen Knott
GM Corporate Communications
[email protected]
+64 21 713 911
Dan Adolph
Head of Investor Relations
[email protected]
+64 22 511 4050
Authorised by Raelene Leonard, General Counsel and Company Secretary.
Let the French have Fonterra brands, Eden Bradfield writes.
The S&P/NZX 50 Index closed at 13,223.53, up 90.32 points or 0.69%.
Total maximum remuneration is now $2m lower at $5.8m.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details